In the present study, we investigated the ability of baicalein to resensitize TAM‐resistant breast cancer cells both in vitro and in vivo, and explored the potential mechanisms underlying HIF‐1α–mediated aerobic glycolysis and mitochondrial dysfunction. Here, HIF1A is linked to breast cancer.